Wiggins KJ - Search Results

1

High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.

Wiggins KJ, McDonald SP, Brown FG, Rosman JB, Johnson DW. Wiggins KJ, et al. Nephrol Dial Transplant. 2007 Oct;22(10):3005-12. doi: 10.1093/ndt/gfm324. Epub 2007 Jun 2. Nephrol Dial Transplant. 2007. PMID: 17545674

2

Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.

Wiggins KJ, Tiauw V, Zhang Y, Gilbert RE, Langham RG, Kelly DJ. Wiggins KJ, et al. Nephrology (Carlton). 2008 Dec;13(8):721-9. doi: 10.1111/j.1440-1797.2008.01008.x. Epub 2008 Sep 25. Nephrology (Carlton). 2008. PMID: 18826488

3

Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditis.

Wiggins KJ, Galanos JW, Hill PA, Scott KV, Langham RG. Wiggins KJ, et al. J Nephrol. 2007 Jul-Aug;20(4):489-94. J Nephrol. 2007. PMID: 17879217 Review.

4

Intradialytic serum protein concentrations differ between nightly nocturnal and conventional haemodialysis.

Wiggins KJ, Somerville CA, Knight R, Simmonds R, Boddington J, Agar JW. Wiggins KJ, et al. Nephrology (Carlton). 2005 Aug;10(4):325-9. doi: 10.1111/j.1440-1797.2005.00417.x. Nephrology (Carlton). 2005. PMID: 16109075

5

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion.

Wiggins KJ, Rumpsfeld M, Hawley CM, O'Shea A, Isbel NM, Campbell SB, Johnson DW. Wiggins KJ, et al. Nephrology (Carlton). 2007 Jun;12(3):218-23. doi: 10.1111/j.1440-1797.2006.00702.x. Nephrology (Carlton). 2007. PMID: 17498115

6

Biocompatible dialysis fluids for peritoneal dialysis.

Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Cho Y, et al. Among authors: wiggins kj. Cochrane Database Syst Rev. 2014 Mar 27;(3):CD007554. doi: 10.1002/14651858.CD007554.pub2. Cochrane Database Syst Rev. 2014. PMID: 24671928 Updated. Review.

7

The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.

Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ. Cho Y, et al. Among authors: wiggins kj. Kidney Int. 2013 Nov;84(5):969-79. doi: 10.1038/ki.2013.190. Epub 2013 May 22. Kidney Int. 2013. PMID: 23698236 Free article. Review.

8

Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, Rosman JB, Bannister KM, Wiggins KJ. Johnson DW, et al. Among authors: wiggins kj. Kidney Int. 2010 May;77(10):904-12. doi: 10.1038/ki.2010.16. Epub 2010 Mar 10. Kidney Int. 2010. PMID: 20375981

9

Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.

Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Barraclough K, et al. Among authors: wiggins kj. Am J Kidney Dis. 2010 Jan;55(1):121-31. doi: 10.1053/j.ajkd.2009.08.020. Epub 2009 Nov 22. Am J Kidney Dis. 2010. PMID: 19932543

10

Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials.

Wiggins KJ, Johnson DW, Craig JC, Strippoli GF. Wiggins KJ, et al. Am J Kidney Dis. 2007 Dec;50(6):967-88. doi: 10.1053/j.ajkd.2007.08.015. Am J Kidney Dis. 2007. PMID: 18037098 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results